PDCD1 and neoplasm: Due to considerable intratumoral heterogeneity, a PD-1/TILs positive or negative tumor can be mischaracterized when interpreting from a small biopsy sample; in this scenario, some PD-1 negative tumors may respond to anti-PD-1 therapy.